BPBlaine A. Pfeifer

Blaine A. Pfeifer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Blaine A. Pfeifer has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Analysis of heterologous taxadiene production in K- and B-derived Escherichia coli

    by Brett A. Boghigian, Daniel Salas, Parayil Kumaran Ajikumar, Gregory Stephanopoulos, Blaine A. Pfeifer

    Taxa-4(5),11(12)-diene is the first dedicated intermediate in the metabolic pathway responsible for synthesizing the anticancer compound Taxol. In this study, the heterologous production of taxadiene was established in and analyzed between K- and B-derived Escherichia coli strains. First, recombinant parameters associated with precursor metabolism (the upstream methylerythritol phosphate (MEP) pathway) and taxadiene biosynthesis (the downstream pathway) were varied to probe the effect different promoters and cellular backgrounds have on taxadiene production. Specifically, upstream MEP pathway genes responsible for the taxadiene precursors, dimethylallyl diphosphate and isopentenyl diphosphate, were tested with an inducible T7 promoter system within K and B E. coli strains. Whereas, inducible T7, Trc, and T5 promoters were tested with the plasmid-borne geranylgeranyl diphosphate synthase and taxadiene synthase genes responsible for the downstream pathway. The K-derivative produced taxadiene roughly 2.5-fold higher than the B-derivative. A transcriptomics study revealed significant differences in pyruvate metabolism between the K and B strains, providing insight into the differences observed in taxadiene biosynthesis and targets for future metabolic engineering efforts. Next, the effect of temperature on cell growth and taxadiene production was analyzed in these two strains, revealing similar phenotypes between the two with 22°C as the optimal production temperature. Lastly, the effect of indole on cell growth was investigated between the two strains, showing that the K-derivative demonstrated greater growth inhibition compared to the B-derivative.


  • Improved E. coli erythromycin a production through the application of metabolic and bioprocess engineering

    by Haoran Zhang, Karin Skalina, Ming Jiang, Blaine A. Pfeifer

    In this report, small‐scale culture and bioreactor experiments were used to compare and improve the heterologous production of the antibiotic erythromycin A across a series of engineered prototype Escherichia coli strains. The original strain, termed BAP1(pBPJW130, pBPJW144, pHZT1, pHZT2, pHZT4, pGro7), was designed to allow full erythromycin A biosynthesis from the exogenous addition of propionate. This strain was then compared against two alternatives hypothesized to increase final product titer. Strain TB3(pBPJW130, pBPJW144, pHZT1, pHZT2, pHZT4, pGro7) is a derivative of BAP1 designed to increase biosynthetic pathway carbon flow as a result of a ygfH deletion; whereas, strain TB3(pBPJW130, pBPJW144, pHZT1, pHZT2, pHZT4‐2, pGro7) provided an extra copy of a key deoxysugar glycosyltransferase gene. Production was compared across the three strains with TB3(pBPJW130, pBPJW144, pHZT1, pHZT2, pHZT4, pGro7) showing significant improvement in erythronolide B (EB), 3‐mycarosylerythronolide B (MEB), and erythromycin A titers. This strain was further tested in the context of batch bioreactor production experiments with time‐course titers leveling at 4 mg/L, representing an approximately sevenfold increase in final erythromycin A titer. © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012


  • Simultaneous production and partitioning of heterologous polyketide and isoprenoid natural products in an Escherichia coli two-phase bioprocess

    by Brett A. Boghigian, Melissa Myint, Jiequn Wu, Blaine A. Pfeifer

    Natural products have long served as rich sources of drugs possessing a wide range of pharmacological activities. The discovery and development of natural product drug candidates is often hampered by the inability to efficiently scale and produce a molecule of interest, due to inherent qualities of the native producer. Heterologous biosynthesis in an engineering and process-friendly host emerged as an option to produce complex natural products. Escherichia coli has previously been utilized to produce complex precursors to two popular natural product drugs, erythromycin and paclitaxel. These two molecules represent two of the largest classes of natural products, polyketides and isoprenoids, respectively. In this study, we have developed a platform E. coli strain capable of simultaneous production of both product precursors at titers greater than 15 mg l−1. The utilization of a two-phase batch bioreactor allowed for very strong in situ separation (having a partitioning coefficient of greater than 5,000), which would facilitate downstream purification processes. The system developed here could also be used in metagenomic studies to screen environmental DNA for natural product discovery and preliminary production experiments.


  • Multi‐factorial engineering of heterologous polyketide production in Escherichia coli reveals complex pathway interactions

    by Brett A. Boghigian, Haoran Zhang, Blaine A. Pfeifer

    Polyketides represent a significant fraction of all natural products. Many possess pharmacological activity which makes them attractive drug candidates. The production of the parent macrocyclic aglycones is catalyzed by multi‐modular polyketide synthases utilizing short‐chain acyl‐CoA monomers. When producing polyketides through heterologous hosts, one must not only functionally express the synthase itself, but activate the machinery used to generate the required substrate acyl‐CoA's. As a result, metabolic engineering of these pathways is necessary for high‐level production of heterologous polyketides. In this study, we over‐express three different pathways for provision of the two substrates (propionyl‐CoA and (2S)‐methylmalonyl‐CoA) utilized for the biosynthesis of 6‐deoxyerythronolide B (6‐dEB; the macrolactone precursor of erythromycin): (1) a propionate → propionyl‐CoA → (2S)‐methylmalonyl‐CoA pathway, (2) a methylmalonate → methylmalonyl‐CoA → propionyl‐CoA pathway, and (3) a succinate → succinyl‐CoA → (2R)‐methylmalonyl‐CoA → (2S)‐methylmalonyl‐CoA → propionyl‐CoA pathway. The current study revealed that propionate is a necessary component for greater than 5 mg L−1 titers. Deletion of the propionyl‐CoA:succinate CoA transferase (ygfH) or over‐expression of the transcriptional activator of short chain fatty acid uptake improved titer to over 100 mg L−1, while the combination of the two improved titer to over 130 mg L−1. The addition of exogenous methylmalonate could also improve titer to over 100 mg L−1. Expression of a Streptomyces coelicolor A3(2) methylmalonyl‐CoA epimerase, in conjunction with over‐expression of Escherichia coli's native methylmalonyl‐CoA mutase, allowed for the incorporation of exogenously fed succinate into the 6‐dEB core. Biotechnol. Bioeng. 2011; 108:1360–1371.


  • Methods and options for the heterologous production of complex natural products

    by Haoran Zhang, Brett A. Boghigian, John Armando, Blaine A. Pfeifer

    Covering: 1990 to 2010 Heterologous biosynthesis has emerged as a viable route to access the beneficial properties of natural products. This development primarily owes to the difficulties encountered when using traditional methods of natural product discovery and production. However, the process of heterologous biosynthesis also presents a number of challenges that have produced an array of creative solutions and noteworthy success stories. In this review, a historical perspective will be presented, together with an analysis of the experimental approaches thus far used to address the unique issues associated with heterologous natural product biosynthesis.


  • Top Cited Papers
    Open Access

    Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli

    by Parayil Kumaran Ajikumar, Wen-Hai Xiao, Keith E. J. Tyo, Yong Wang, Fritz Simeon, Effendi Leonard, Oliver Mucha, Too Heng Phon, Blaine Pfeifer, Gregory Stephanopoulos

    Toward Microbial Taxol: Taxol, a minor chemical constituent of yew tree bark, has provided a potent cancer treatment. Production methods presently rely on plant cell cultures. Ajikumar et al. (p. 70 ; see the Perspective by Liu and Khosla ) engineered Escherichia coli cells to produce a key taxol precursor, in which the polycyclic carbon skeleton is intact. The approach relied on optimizing the relative activity of two pathways, the first of which synthesized isoprenoid building blocks that were then stitched together with the second pathway. Accumulation of indole as a by-product inhibited the isoprenoid pathway—an insight that should facilitate more efficient engineered biosynthesis of a wide range of commercially important isoprenoid derivatives.


  • Construction and performance of heterologous polyketide-producing K-12- and B-derived Escherichia coli

    by J. Wu, B.A. Boghigian, M. Myint, H. Zhang, S. Zhang, B.A. Pfeifer

    Escherichia coli has emerged as a viable heterologous host for the production of complex, polyketide natural compounds. In this study, polyketide biosynthesis was compared between different E. coli strains for the purpose of better understanding and improving heterologous production. Both B and K-12 E. coli strains were genetically modified to support heterologous polyketide biosynthesis [specifically, 6-deoxyerythronolide B (6dEB)]. Polyketide production was analysed using a helper plasmid designed to overcome rare codon usage within E. coli. Each strain was analysed for recombinant protein production, precursor consumption, by-product production, and 6dEB biosynthesis. Of the strains tested for biosynthesis, 6dEB production was greatest for E. coli B strains. When comparing biosynthetic improvements as a function of mRNA stability vs codon bias, increased 6dEB titres were observed when additional rare codon tRNA molecules were provided. Escherichia coli B strains and the use of tRNA supplementation led to improved 6dEB polyketide titres. Given the medicinal potential and growing field of polyketide heterologous biosynthesis, the current study provides insight into host-specific genetic backgrounds and gene expression parameters aiding polyketide production through E. coli.


  • Open Access

    Utilizing elementary mode analysis, pathway thermodynamics, and a genetic algorithm for metabolic flux determination and optimal metabolic network design

    by Brett A Boghigian, Hai Shi, Kyongbum Lee, Blaine A Pfeifer

    Background: Microbial hosts offer a number of unique advantages when used as production systems for both native and heterologous small-molecules. These advantages include high selectivity and benign environmental impact; however, a principal drawback is low yield and/or productivity, which limits economic viability. Therefore a major challenge in developing a microbial production system is to maximize formation of a specific product while sustaining cell growth. Tools to rationally reconfigure microbial metabolism for these potentially conflicting objectives remain limited. Exhaustively exploring combinations of genetic modifications is both experimentally and computationally inefficient, and can become intractable when multiple gene deletions or insertions need to be considered. Alternatively, the search for desirable gene modifications may be solved heuristically as an evolutionary optimization problem. In this study, we combine a genetic algorithm and elementary mode analysis to develop an optimization framework for evolving metabolic networks with energetically favorable pathways for production of both biomass and a compound of interest.Results: Utilization of thermodynamically-weighted elementary modes for flux reconstruction ofE. colicentral metabolism revealed two clusters of EMs with respect to their ΔGp°. For proof of principle testing, the algorithm was applied to ethanol and lycopene production inE. coli. The algorithm was used to optimize product formation, biomass formation, and product and biomass formation simultaneously. Predicted knockouts often matched those that have previously been implemented experimentally for improved product formation. The performance of a multi-objective genetic algorithm showed that it is better to couple the two objectives in a single objective genetic algorithm.Conclusion: A computationally tractable framework is presented for the redesign of metabolic networks for maximal product formation combining elementary mode analysis (a form of convex analysis), pathway thermodynamics, and a genetic algorithm to optimize the production of two industrially-relevant products, ethanol and lycopene, fromE. coli. The designed algorithm can be applied to any small-scale model of cellular metabolism theoretically utilizing any substrate and applied towards the production of any product.


  • Investigating the role of native propionyl‐CoA and methylmalonyl‐CoA metabolism on heterologous polyketide production in Escherichia coli

    by Haoran Zhang, Brett A. Boghigian, Blaine A. Pfeifer

    6‐Deoxyerythronolide B (6dEB) is the macrocyclic aglycone precursor of the antibiotic natural product erythromycin. Heterologous production of 6dEB in Escherichia coli was accomplished, in part, by designed over‐expression of a native prpE gene (encoding a propionyl‐CoA synthetase) and heterologous pcc genes (encoding a propionyl‐CoA carboxylase) to supply the needed propionyl‐CoA and (2S)‐methylmalonyl‐CoA biosynthetic substrates. Separate E. coli metabolism includes three enzymes, Sbm (a methylmalonyl‐CoA mutase), YgfG (a methylmalonyl‐CoA decarboxylase), and YgfH (a propionyl‐CoA:succinate CoA transferase), also involved in propionyl‐CoA and methylmalonyl‐CoA metabolism. In this study, the sbm, ygfG, and ygfH genes were individually deleted and over‐expressed to investigate their effect on heterologous 6dEB production. Our results indicate that the deletion and over‐expression of sbm did not influence 6dEB production; ygfG over‐expression reduced 6dEB production by fourfold while ygfH deletion increased 6dEB titers from 65 to 129 mg/L in shake flask experiments. It was also found that native E. coli metabolism could support 6dEB biosynthesis in the absence of exogenous propionate and the substrate provision pcc genes. Lastly, the effect of the ygfH deletion was tested in batch bioreactor cultures in which 6dEB titers improved from 206 to 527 mg/L. Biotechnol. Bioeng. 2010; 105: 567–573.


  • Efficient experimental design and micro‐scale medium enhancement of 6‐deoxyerythronolide B production through Escherichia coli

    by Michael Pistorino, Blaine A. Pfeifer

    The recent use of heterologous hosts to produce natural products has shown significant potential, although limitations still exist regarding optimal production titers. In this study, we utilize micro‐scale cultures and well‐defined screening methods to identify key medium components that influence the heterologous production of the complex polyketide 6‐deoxyerythronolide B (6dEB) through E. coli. It was determined that tryptone had a significant effect on 6dEB production and could supplement substrate requirements and improve recombinant protein levels of the essential deoxyerythronolide B synthase (DEBS) which catalyze 6dEB conversion. As a result, the study (1) demonstrates the feasibility of micro‐scale cultures to study E. coli 6dEB production and effectively model larger‐scale cultures; (2) identifies an enhanced medium which generates over 160 mg L−1 6dEB (a 22‐fold improvement over current culture media); and (3) provides new insight and understanding related to the heterologous production of 6dEB from E. coli. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009